Crinetics Pharmaceuticals, Inc. (CRNX) Shareholders’ equity 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) shareholders’ equity at each fiscal year-end, per SEC filings.
$992.1MFY2025 · since FY2016: -$6.2M → $992.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $992.1M | -25.1% |
| FY2024 | $1.3B | +145.7% |
| FY2023 | $539.1M | +70.4% |
| FY2022 | $316.3M | -4.7% |
| FY2021 | $331.9M | +96.5% |
| FY2020 | $168.9M | +44.2% |
| FY2019 | $117.1M | -26.9% |
| FY2018 | $160.2M | +1166.6% |
| FY2017 | -$15.0M | -142.1% |
| FY2016 | -$6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice